Astrazeneca PLC ORD SHS $0.25
Astrazeneca PLC ORD SHS $0.25/ GB0009895292 /
AZN
|
5/31/2024 9:00:00 PM
|
Chg.
+162.0000
|
Volume |
Bid5/31/2024 |
Ask5/31/2024 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
12,190.0000GBX
|
+1.35%
|
3.37 mill.
Turnover(GBP): 410.69 mill. |
11,850.0000Bid Size: 500 |
12,300.0000Ask Size: 300 |
188.9 bill.GBP |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
3.84 USD |
81.13% |
| EPS Diluted: |
- USD |
80.57% |
| Revenues per Share: |
29.55 USD |
3.28% |
| Book Value per Share: |
25.25 USD |
5.68% |
| Cash Flow per Share: |
6.67 USD |
5.46% |
| Dividend per Share: |
2.90 USD |
0.00% |
| Total |
in mill. |
|
| Revenues: |
45,811.00 USD |
3.29% |
| Net Income: |
5,955.00 USD |
84.48% |
| Operating Cash Flow: |
10,345.00 USD |
- |
| Cash and Cash Equivalents: |
5,840.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
40.46 |
35.16 |
| P/S Ratio: |
5.26 |
4.57 |
| P/BV ratio: |
6.15 |
5.35 |
| P/CF Ratio: |
23.28 |
20.23 |
| PEG: |
0.50 |
0.43 |
| Earnings Yield: |
2.47% |
2.84% |
| Dividend Yield: |
1.87% |
2.15% |
| Market Capitalization |
|
| Market Capitalization: |
188.9 bill. GBP |
164.16 bill. GBP |
| Free Float Market Cap.: |
139.03 bill. GBP |
- GBP |
| Market Cap. / Employee: |
2.1 mill. GBP |
1.83 mill. GBP |
| Shares Outstanding: |
1.55 bill. |
|
Profitability
| Gross Profit Margin: |
81.95% |
| EBIT Margin: |
17.88% |
| Net Profit Margin: |
13.00% |
| Return on Equity: |
15.21% |
| Return on Assets: |
5.89% |
Financial Strength
| Liquidity I / Cash Ratio: |
19.12% |
| Liquidity II / Quick Ratio: |
58.82% |
| Liquidity III / Current Ratio: |
82.03% |
| Debt / Equity Ratio: |
158.33% |
| Dynam. Debt / Equity Ratio: |
599.09% |
Efficiency
| Employees: |
89,900 |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
509,577.31 USD |
| Net Income / Employee: |
66,240.27 USD |
| Total Assets / Employee: |
1,124,794.22 USD |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
